Bayer CropScience Ltd (BAYERCROP) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506285 | NSE: BAYERCROP | Pesticides & Agrochemicals | Small Cap

Bayer CropScience Share Price

4,519.75 11.95 0.27%
as on 05-Dec'25 12:17

Bayer CropScience Ltd (BAYERCROP) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506285 | NSE: BAYERCROP | Pesticides & Agrochemicals | Small Cap

DeciZen - make an informed investing decision on Bayer CropScience

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Bayer CropScience stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
33.27
Market Cap:
20,259 Cr.
52-wk low:
4,220.1
52-wk high:
6,540

Is Bayer CropScience Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Bayer CropScience: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bayer CropScience Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 25.4%23.4%21.7%24.4%24.8%31.5%33.9%38.7%34.6%25.4%-
Value Creation
Index
0.90.70.60.80.81.81.51.92.11.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2,7692,8032,7103,1673,6094,2614,7345,1405,1065,4735,571
Sales YoY Gr.-1.2%-3.3%16.9%14%18.1%11.1%8.6%-0.7%7.2%-
Adj EPS 89.883.288.599.7124.9106.8133.1150.8162.9123.6135.5
YoY Gr.--7.4%6.4%12.6%25.3%-14.5%24.7%13.3%8%-24.1%-
BVPS (₹) 519.6581518.5649.8572.9568562.2604634.6634.8695
Adj Net
Profit
317294304342561480598678732556609
Cash Flow from Ops. 207157121433666687216609952262-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.9%8.7%5%7.2%
Adj EPS 3.6%-0.2%-2.4%-24.1%
BVPS2.3%2.1%4.1%0%
Share Price 2.3% -2.6% -0.8% -25.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
16.415.115.81723.318.723.625.926.319.520.4
Op. Profit
Mgn %
15.814.915.315.420.21917.117.918.712.613.4
Net Profit
Mgn %
11.510.511.210.815.611.312.613.214.310.210.9
Debt to
Equity
00000000000
Working Cap
Days
326357439411389345349358353371160
Cash Conv.
Cycle
101110131101817477878710384

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Bayer CropScience Ltd.

Standalone Consolidated
TTM EPS (₹) 135.5 12.3
TTM Sales (₹ Cr.) 5,571 783
BVPS (₹.) 695 0
Reserves (₹ Cr.) 3,079 294
P/BV 6.49 0.00
PE 33.27 365.63
From the Market
52 Week Low / High (₹) 4220.05 / 6539.95
All Time Low / High (₹) 34.13 / 7189.90
Market Cap (₹ Cr.) 20,259
Equity (₹ Cr.) 44.9
Face Value (₹) 10
Industry PE 25.9

Management X-Ray of Bayer CropScience:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Bayer CropScience - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Bayer CropScience

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales2,7692,8032,7103,1673,6094,2614,7345,1405,1065,473
Operating Expenses 2,3352,3912,3012,6872,8843,4523,9294,2254,1524,785
Manufacturing Costs288189114200204268277282286334
Material Costs1,4321,5731,5441,5771,8222,3212,5362,6932,7803,242
Employee Cost 221246264364362362463534435450
Other Costs 394383379545497501653716651760
Operating Profit 434412409481726810806915954688
Operating Profit Margin (%) 15.7%14.7%15.1%15.2%20.1%19.0%17.0%17.8%18.7%12.6%
Other Income 827239536766607381121
Interest 1071110141313222017
Depreciation 25293344657465807485
Exceptional Items 0000-13055910400
Profit Before Tax 482448404480583795847990941707
Tax 167157104143109301202232201139
Profit After Tax 315291300337475493645758741568
PAT Margin (%) 11.4%10.4%11.1%10.6%13.1%11.6%13.6%14.8%14.5%10.4%
Adjusted EPS (₹)89.082.287.598.3105.7109.8143.7168.9164.9126.5
Dividend Payout Ratio (%)19%21%21%18%24%105%104%77%85%99%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1,8392,0571,7782,2292,5732,5502,5242,7122,8492,850
Share Capital 35353434454545454545
Reserves 1,8042,0211,7442,1952,5282,5052,4792,6672,8052,806
Minority Interest0000000000
Debt0000200000
Long Term Debt0000000000
Short Term Debt0000200000
Trade Payables2042872846444758308208736051,098
Others Liabilities 1,6932,0812,1682,6642,8793,2263,6183,9144,1624,460
Total Liabilities 3,7374,4254,2305,5375,9286,6076,9627,5007,6168,408

Fixed Assets

Gross Block314361384548635649713764761846
Accumulated Depreciation245080139197254272328360385
Net Fixed Assets 290311304409438395441437401461
CWIP 17243647567698109119119
Investments 365000415239415435
Inventories6657687401,1579641,3251,5121,8071,5452,362
Trade Receivables4055576596997187551,005976960952
Cash Equivalents 7638394185821,0711,2107878681,164894
Others Assets 1,5601,8772,0732,6432,6412,7943,0793,2623,3743,586
Total Assets 3,7374,4254,2305,5375,9286,6076,9627,5007,6168,408

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 207157121433666687216609952262
PBT 482448404480583795847990941707
Adjustment -22538671916239-010872
Changes in Working Capital -87-148-2259028-7-406-14134-355
Tax Paid -165-148-95-205-136-163-264-240-132-162
Cash Flow From Investing Activity 16-838-415-2976483086
Capex -37-49-42-55-28-31-47-73-39-40
Net Investments -11-1350-396-40-123122237
Others 64543036393988343889
Cash Flow From Financing Activity -590-73-581-158-148-556-703-613-656-619
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -5-1-4-5-2-3-4-11-11-9
Dividend Paid -62-60-60-126-102-516-673-561-607-561
Others -523-12-517-27-44-37-26-41-38-50
Net Cash Flow -36776-421-140489138-42479296-272

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)16.2714.9415.6516.8319.7719.2525.4328.9626.6319.93
ROCE (%)25.3923.3521.6524.4124.831.533.8838.6734.5625.42
Asset Turnover Ratio0.740.720.640.720.720.770.80.820.810.78
PAT to CFO Conversion(x)0.660.540.41.281.41.390.330.81.280.46
Working Capital Days
Receivable Days62608171635659615856
Inventory Days788910099948695103100113
Payable Days6057681071121031191159796

Bayer CropScience Ltd Stock News

Bayer CropScience Ltd FAQs

The current trading price of Bayer CropScience on 05-Dec-2025 12:17 is ₹4,519.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Bayer CropScience stood at ₹20,259.
The latest P/E ratio of Bayer CropScience as of 04-Dec-2025 is 33.27.
The latest P/B ratio of Bayer CropScience as of 04-Dec-2025 is 6.49.
The 52-week high of Bayer CropScience is ₹6,540 and the 52-week low is ₹4,220.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bayer CropScience is ₹5,571 ( Cr.) .

About Bayer CropScience Ltd

Bayer CropScience is the flagship company of the Bayer Group in India and is publicly listed on the Bombay Stock Exchange. It is engaged in manufacturing of crop protection products, non agricultural pest-control, seeds and plant biotechnology. The company enjoys a unique position in the market because of its capability to offer new innovative products, technologies, processes, services and business models. With its innovative products, it is contributing to finding solutions to some of the major challenges of its time. The company remains committed to improving lives by advancing nutrition and healthcare solutions for the country’s growing population.

Business area of the company

The company’s Crop Science division is the largest for Bayer in India with businesses in seeds & traits, crop protection, digital farming and environmental science (non-agricultural pest control). Its robust crop protection portfolio includes products to manage insects, pests, weeds and diseases. It also includes bilogical solutions, that use nature’s own defenses to protect crops. Its broad range of high-quality hybrid seeds includes cutting-edge traits for high-yielding crops with improved weed management and superior insect control. Its expertise and innovations in digital farming provide farmers with a deeper understanding of their fields so they can utilize their inputs and natural resources as efficiently as possible. The company also has products that focus on non-agricultural applications in the form of products and services for vector control and professional pest control.

The company’s Pharmaceuticals division in India operates as Bayer Zydus Pharma, a joint venture between Bayer and Zydus Cadila. The focus of this business is on prescription products, especially for cardiology and women’s health care and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents. Its Consumer Health division is focused on making self-care for a better life a reality for billions of people around the world through everyday healthcare. Its Animal Health business develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.

Awards:

  • Bayer India wins ‘Aon Best Employer in India 2017’ award.
  • Bayer India wins ‘Aon Best Employer in India 2018’ award.
  • Bayer India wins the Mercer NDTV Employer Excellence Award 2018.
  • Bayer India wins ‘Aon Best Employer in India 2019’ award for the third time in a row.
  • Bayer received a 'Great Places to Work' certification.

Milestones:

  • 1863: The company is founded on August 1, 1863 by dye salesman Friedrich Bayer and the master dyer Johann Friedrich Weskott in Wuppertal, Germany - a 19th century startup with tremendous potential.
  • 1896: First wholly-owned subsidiary of Bayer in Asia ‘Farbenfabriken Bayer and Company Limited’ is set-up in Mumbai.
  • 1958: Bayer CropScience Ltd. – the listed entity for Bayer in India - was incorporated on September 9, 1958.
  • 1958: Bayer establishes Bayer Agrochem Private Limited in India.
  • 1963: The name of Bayer Agrochem changes to Bayer (India) Limited.
  • 1969: The company commences operations of a major plant in Thane.
  • 2001: Bayer acquires Aventis CropScience.
  • 2004: First Imidacloprid production facility outside Germany is inaugurated in Vapi.
  • 2005: Lanxess AG is spun off from the Bayer Group.
  • 2006: Takeover of Schering AG, Berlin, Germany.
  • 2011: Bayer Zydus Pharma is set up as a 50:50 joint venture between Bayer HealthCare and Zydus Cadilla.
  • 2013: The Seeds business unit (Bayer BioScience) of Bayer CropScience, India opens a multi-crop breeding station in Chandippa, near Hyderabad and a Mustard Breeding Station in Palwal, Haryana.
  • 2014: New Headquarters of Bayer South Asia inaugurated at Thane.
  • 2015: Bayer MaterialScience is now independent under the name Covestro.
  • 2016: In September, Bayer and Monsanto sign a binding merger agreement.
  • 2017: Bayer kicks off ‘LEAPS‘ globally as a new approach to complement the existing R&D capabilities and which aims to enable breakthrough innovations across healthcare and agriculture.
  • 2018: Bayer concludes process to sell Covestro.
  • 2019: Bayer completes Monsanto integration in India in September.
  • 2019: A new plant is inaugurated at Bayer‘s Himatnagar site, strengthening company’s manufacturing footprint in Gujarat.
  • 2020: FOGSI and Bayer Zydus Pharma collaborate to drive adoption of digital technology solution ‘Ask Tanu’.
  • 2020: Bayer’s Aflibercept injection (EyleaTM) for intravitreal use receives DCGI Approval for Diabetic Macular Edema Indication.
  • 2020: Bayer partners with ITC e-Choupal 4.0 to support farmers.
  • 2020: Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×